David Schenkein resigns from Agios’ board; Moderna hires Roivant exec as chief marketing officer
David Schenkein will step down from Agios Pharmaceuticals’ board of directors at the end of the month “to devote more time to his other commitments” …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
